Literature DB >> 3572026

The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.

I Yamada, S Seki, O Matsubara, S Ito, S Suzuki, T Kasuga.   

Abstract

L-3,4-Dihydroxyphenylalanine (L-dopa) and its structural analogs are known to be potently cytotoxic to melanoma cells. We examined the effects of cysteinylcatechols and related compounds, which were newly synthesized as cysteinyl derivatives of L-dopa, on the growth of human melanoma cells in vitro, and their actions were compared with those of L-dopa. 4-S- and 3-S-Cysteinylcatechols showed significantly more potent cytotoxicity to melanoma cells than did L-dopa, and 2-S-cysteinylhydroquinone was next to the catechols in potency. The mechanism of action may involve interaction with the melanocyte-specific enzyme, tyrosinase, for which the cysteinylcatechols could become a better substrate than L-dopa itself. 4-S-Cysteaminylphenol was almost comparable to L-dopa in cytotoxicity, suggesting that this phenol might be oxidized to the corresponding catechol by tyrosinase within the melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572026     DOI: 10.1111/1523-1747.ep12470098

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.

Authors:  E P Kable; P G Parsons
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.

Authors:  Yasuaki Tamura; Akira Ito; Kazumasa Wakamatsu; Takafumi Kamiya; Toshihiko Torigoe; Hiroyuki Honda; Toshiharu Yamashita; Hisashi Uhara; Shosuke Ito; Kowichi Jimbow
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

3.  In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.

Authors:  M Kitagawa; T Nemoto; S Seki; S Ito; T Kasuga
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.

Authors:  I Yamada; S Seki; S Ito; S Suzuki; O Matsubara; T Kasuga
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.